While many tumor-targeted PD-1/PD-L1 ICI delivery methods aim to localize the drugs using carrier vehicles and tumoritropic agents as discussed in subsequent sections, the simplest strategy is to directly deposit the mAb into the tumor (i.e., IT delivery). Here, CD274 is linked to neoplasm.